3,4-Dihydroxymethamphetamine (HHMA). A major in vivo 3,4-methylenedioxymethamphetamine (MDMA) metabolite in humans.

Segura, M; Ortuño, J; Farré, M; McLure, J A; Pujadas, M; Pizarro, N; Llebaria, A; Joglar, J; Roset, P N; Segura, J; de La Torre, R

Segura, M; Ortuño, J; Farré, M; McLure, J A; Pujadas, M; Pizarro, N; Llebaria, A; Joglar, J; Roset, P N; Segura, J; de La Torre, R.

Affiliation

Segura M; Pharmacology Research Unit, Institut Municipal d'Investigació Mèdica (IMIM), Barcelona, Spain.

Chem Res Toxicol ; 14(9): 1203-8, 2001 Sep.

Article in En | MEDLINE | ID: mdl-11559034

Subject(s)

Deoxyepinephrine/analogs & derivatives; Deoxyepinephrine/blood; Deoxyepinephrine/urine; Hallucinogens/adverse effects; Hallucinogens/metabolism; N-Methyl-3,4-methylenedioxyamphetamine/adverse effects; N-Methyl-3,4-methylenedioxyamphetamine/metabolism; Adult; Chromatography, High Pressure Liquid/methods; Humans; Male; Sensitivity and Specificity; Toxicity Tests

Search on Google

XML

PubMed Links

Database: MEDLINE Main subject: N-Methyl-3,4-methylenedioxyamphetamine / Deoxyepinephrine / Hallucinogens Type of study: Diagnostic_studies Limits: Adult / Humans / Male Language: En Year: 2001 Type: Article

Search on Google

XML

PubMed Links